Public Market Listing
9966HKEX
Live quotes, historical charts, and market capitalization for Alphamab Oncology are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(4 total)
4Total Assets
0Approved
4Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | HER2 (biparatopic — extracellular domains II and IV)Antibody–drug conjugate | Breast Cancer HR+/HER2- Metastatic Breast Cancer | |
| Phase 3 | HER3 + TROP2Antibody–drug conjugate | Non-Small Cell Lung CancerBreast Cancer HR+/HER2- Metastatic Breast Cancer | |
| Phase 3 | HER2 (JSKN003 ADC component) + PD-L1 (envafolimab component)Combination | Non-Small Cell Lung Cancer | |
| Phase 3 | PD-L1 + CTLA-4Multispecific antibody | Non-Small Cell Lung Cancer |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.